Redox-sensitive signaling factors as a novel molecular targets for cancer therapy
Authors:
- Tony Jau Cheng WangTWTony Jau Cheng Wang
- Phuongmai NguyenPNPhuongmai Nguyen
- Lunching SunLSLunching Sun
- Kheem BishtKBKheem Bisht
- DeeDee SmartDSDeeDee Smart
- David GiusDGDavid Gius
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 8 (5) , 322-330
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c releaseBiochemical and Biophysical Research Communications, 2005
- Cancer cell death by programmed necrosis?Drug Resistance Updates, 2004
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiationOncogene, 2002
- Geranylgeranylacetone Enhances Expression of Thioredoxin and Suppresses Ethanol-Induced Cytotoxicity in Cultured HepatocytesBiochemical and Biophysical Research Communications, 2000
- Nucleoredoxin, Glutaredoxin, and Thioredoxin Differentially Regulate NF-κB, AP-1, and CREB Activation in HEK293 CellsBiochemical and Biophysical Research Communications, 2000
- Zen and the art of Fos and JunNature, 1995
- Redox-dependent shift of OxyR-DNA contacts along an extended DNA-binding site: A mechanism for differential promoter selectionCell, 1994
- Signal transduction: the nuclear targetCurrent Opinion in Cell Biology, 1992
- On the Origin of Cancer CellsScience, 1956